A controlled, randomised clinical trial of immunotherapy was performed in 301 patients with stage B or C colorectal cancer. The immunotherapy treatment consisted of 18 vaccinations over a 2 year period following surgery with a combination of BCG given by scarification plus subcutaneous injection of
Randomized Study of Adjuvant Immunotherapy with Autologous Tumor Cells and BCG in Renal Cancer
โ Scribed by E. GALLIGIONI; M. FRANCINI; M. QUAIA; A. CARBONE; A. SPADA; C. SACCO; D. FAVARO; M. SANTAROSA; G. CARMIGNANI; D. Di DONNA; G. MAZZA; S. VIGGIANO; G. FIACCAVENTO; V. Dal BO; R. TALAMINI
- Book ID
- 119869550
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 145 KB
- Volume
- 690
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient
## Background: Patients with metastatic melanoma to their regional lymph nodes have a poor prognosis despite lymphadenectomy. in an attempt to improve their survival, this feasibility study was undertaken. ## Methods: Twenty-two melanoma patients, who presented with enlarged regional lymph nodes,